Roche Launches Next-Generation Sequencing Platform Axelios 1

Expects Global Research-Use-Only Commercial Release In Summer 2026 To Pursue Development Roadmap For Clinical Market Initial Focus On North America And Select Markets In Europe And APAC Axelios 1 Platform Priced At USD 750K In The US